The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Ellen Miller Sonet named chief strategy and alliance officer of CancerCare

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

ELLEN MILLER SONET was named chief strategy and alliance officer of CancerCare.

Sonet will serve on the nonprofit’s executive leadership team. She previously served for nearly 17 years as vice president of marketing at Memorial Sloan-Kettering Cancer Center.

Prior to her tenure at Memorial Sloan-Kettering, Sonet worked in pharmaceutical marketing on brands such as Afrin Nasal Spray and Bayer Aspirin.

YOU MAY BE INTERESTED IN

Regulatory News

FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial

FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
By Jacquelyn Cobb and Paul Goldberg

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account